Review
Open access
Aug 2026
Gut microbiota and the gut–liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities
Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common chronic liver diseases worldwide, affecting more than one-third of adults and imposing a substantial hepatic and systemic metabolic burden. With the continuing rise in obesity, type 2 diabetes mellitus, and related metabolic abno...
Jing-Jing Liu, Mei Zhao, Shu-Jing Wang et al.
· Frontiers in Pharmacology · 0 citations